Project Lead

[imported_Joe]

Spaces and scholarships are still available for
Project LEAD Washington, DC! The course is
scheduled for November 2-6, 2005 and applications are due September 3rd!


Project LEAD (Leadership, Education and Advocacy
Development) trains advocates in the concepts and
language of the science of breast cancer. The
goal of the program is to give participants the
tools to serve as consumer advocates at every
level of the research and policy process. This
increase in knowledge and understanding of the
science of breast cancer serves to enhance
participants' effectiveness in community work as well.


Project LEAD is an intensive four-day course
focusing on the basic biology of breast cancer,
principles of genetics and genomics, the
relationship of DNA, RNA and proteins, critical
appraisals of scientific studies, epidemiologic
principles and study designs and training in
applying this knowledge to the research world.
There is no cost to attend this course; the
participant only pays for travel and
accommodations. A limited number of scholarships
are available to defray the cost of travel and accommodations.


If you are a breast cancer activist who is
interested in deepening your knowledge and skills
in the science and research arenas, I hope you
will consider applying. You can read more about
Project LEAD® and download the application at our
Web site, www.stopbreastcancer.org We encourage
you to take this next step in your advocacy education and training.


Julia Hill
National Breast Cancer Coalition
1101 17th St, NW Suite 1300
Washington, DC 20036
(202) 973-0577
fax: (202) 265- 6854

[Gina]

Thanks Joe,

Actually, I live only a few minutes from downtown DC so I will download the application and try to arrange my work schedule to attend. Sounds right up my alley.

Sorry, that as a new comer I have somewhat stormed the site with lengthly and detailed posts but I have a long and horrid past with this disease and have spent years researching just for myself and am now at a point where I feel I have a least a few solid and well-researched tid bits to GIVE back. Mostly they are only educated opinions, but still I hope they will be of some help.

I was shocked and appalled to learn that so many folks on this site are apparently ignorant of their own tumor markers...and granted, I know there are patches of her-2 folks who will not have demonstable markers, the bulk of us do have and we need to know them. Is there any way to get the word out to the oncologists to at least start trying to get the patients their markers so they both can use them in a bio-feedback setting to better adjust Herceptin dosage and avoid possible cardiac damage or worse??? As I say everywhere, in this day and age, where her-2 is concerned, there is no reason to guess if you have it or guess how badly you have it. Of course, there is still always a place for scans and other tests, but why are some oncology offices "up" on the markers while others lag pitifully behind???

Thanks again, if I attend the Nov. conference will surely "share" what I learn...smile.

Gina